Detalhe da pesquisa
1.
Combination lenalidomide-rituximab immunotherapy activates anti-tumour immunity and induces tumour cell death by complementary mechanisms of action in follicular lymphoma.
Br J Haematol;
185(2): 240-253, 2019 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30767211
2.
Increased Risk of Colorectal Cancer in Patients With Multiple Serrated Polyps and Their First-Degree Relatives.
Gastroenterology;
153(1): 106-112.e2, 2017 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28400194
3.
New insights into POLE and POLD1 germline mutations in familial colorectal cancer and polyposis.
Hum Mol Genet;
23(13): 3506-12, 2014 Jul 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24501277
4.
Endoscopic surveillance in patients with multiple (10-100) colorectal polyps.
Endoscopy;
48(1): 56-61, 2016 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26165738
5.
Prevalence of MLH1 constitutional epimutations as a cause of Lynch syndrome in unselected versus selected consecutive series of patients with colorectal cancer.
J Med Genet;
52(7): 498-502, 2015 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25908759
6.
Risk of cancer in cases of suspected lynch syndrome without germline mutation.
Gastroenterology;
144(5): 926-932.e1; quiz e13-4, 2013 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23354017
7.
Clinical subtypes and molecular characteristics of serrated polyposis syndrome.
Clin Gastroenterol Hepatol;
11(6): 705-11; quiz e46, 2013 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23376323
8.
Comparison between universal molecular screening for Lynch syndrome and revised Bethesda guidelines in a large population-based cohort of patients with colorectal cancer.
Gut;
61(6): 865-72, 2012 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21868491
9.
Evidence for classification of c.1852_1853AA>GC in MLH1 as a neutral variant for Lynch syndrome.
BMC Med Genet;
12: 12, 2011 Jan 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21247423
10.
The TGFBR1*6A allele is not associated with susceptibility to colorectal cancer in a Spanish population: a case-control study.
BMC Cancer;
9: 193, 2009 Jun 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19538729
11.
The Int7G24A variant of transforming growth factor-beta receptor type I is a risk factor for colorectal cancer in the male Spanish population: a case-control study.
BMC Cancer;
9: 406, 2009 Nov 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19930569
12.
KRAS and BRAF somatic mutations in colonic polyps and the risk of metachronous neoplasia.
PLoS One;
12(9): e0184937, 2017.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28953955
13.
Efficacy of Adjuvant 5-Fluorouracil Therapy for Patients with EMAST-Positive Stage II/III Colorectal Cancer.
PLoS One;
10(5): e0127591, 2015.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25996601
14.
IGFBP3 methylation is a novel diagnostic and predictive biomarker in colorectal cancer.
PLoS One;
9(8): e104285, 2014.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25127039
15.
Prevalence and characteristics of MUTYH-associated polyposis in patients with multiple adenomatous and serrated polyps.
Clin Cancer Res;
20(5): 1158-68, 2014 Mar 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24470512
16.
Prevalence of Lynch syndrome among patients with newly diagnosed endometrial cancers.
PLoS One;
8(11): e79737, 2013.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24244552
17.
Serrated polyposis syndrome: molecular, pathological and clinical aspects.
World J Gastroenterol;
18(20): 2452-61, 2012 May 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22654442
18.
TGFBR1 intralocus epistatic interaction as a risk factor for colorectal cancer.
PLoS One;
7(1): e30812, 2012.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22292045
19.
Biallelic MYH germline mutations as cause of Muir-Torre syndrome.
Fam Cancer;
9(2): 151-4, 2010 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19998059
20.
EPCAM germ line deletions as causes of Lynch syndrome in Spanish patients.
J Mol Diagn;
12(6): 765-70, 2010 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20864635